BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 112103
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.112103
Table 1 Baseline data analysis between the acute respiratory distress syndrome group and the non-acute respiratory distress syndrome group, n (%)
Variables
Total (n = 176)
Non-ARDS group (n = 134)
ARDS group (n = 42)
Statistic
P value
Age, mean ± SD64.36 ± 5.0763.74 ± 4.8666.36 ± 5.28t = -2.990.003
BMI, mean ± SD22.92 ± 3.2922.98 ± 3.3522.73 ± 3.12t = 0.430.669
Preoperative RBC, mean ± SD3.62 ± 0.653.58 ± 0.613.75 ± 0.79t = -1.210.230
Preoperative WBC, mean ± SD5.80 ± 0.975.71 ± 0.896.08 ± 1.14t = -2.120.035
Preoperative ALB, mean ± SD42.14 ± 2.5242.41 ± 2.5341.27 ± 2.34t = 2.620.010
Preoperative Hb, mean ± SD130.20 ± 9.66130.72 ± 9.69128.57 ± 9.47t = 1.260.211
Preoperative PLT, mean ± SD191.44 ± 25.80189.47 ± 24.55197.72 ± 28.86t = -1.820.071
FEV1%, mean ± SD88.13 ± 15.3290.17 ± 15.6281.64 ± 12.37t = 3.230.001
FVC%, mean ± SD78.11 ± 9.6779.24 ± 9.7574.47 ± 8.54t = 2.840.005
Operation time, mean ± SD182.83 ± 23.05181.36 ± 22.51187.52 ± 24.37t = -1.520.131
Preoperative bleeding, mean ± SD51.68 ± 12.4051.19 ± 11.7453.24 ± 14.33t = -0.940.351
Sexχ2 = 0.080.784
Female66 (37.50)51 (38.06)15 (35.71)
Male110 (62.50)83 (61.94)27 (64.29)
Smokingχ2 = 4.810.028
No93 (52.84)77 (57.46)16 (38.10)
Yes83 (47.16)57 (42.54)26 (61.90)
Hypertensionχ2 = 0.670.414
No114 (64.77)89 (66.42)25 (59.52)
Yes62 (35.23)45 (33.58)17 (40.48)
Diabetesχ2 = 0.890.345
No163 (92.61)126 (94.03)37 (88.10)
Yes13 (7.39)8 (5.97)5 (11.90)
Tumor locationχ2 = 4.240.236
Intestine86 (48.86)71 (52.99)15 (35.71)
Stomach34 (19.32)25 (18.66)9 (21.43)
Liver and gallbladder30 (17.05)20 (14.93)10 (23.81)
Pancreas26 (14.77)18 (13.43)8 (19.05)
TNM stagingχ2 = 5.580.018
I/II99 (56.25)82 (61.19)17 (40.48)
III/IV77 (43.75)52 (38.81)25 (59.52)
Preoperative pulmonary infectionχ2 = 5.160.023
No125 (71.02)101 (75.37)24 (57.14)
Yes51 (28.98)33 (24.63)18 (42.86)
Surgical methodχ2 = 1.700.192
Laparoscopic surgery127 (72.16)100 (74.63)27 (64.29)
Open surgery49 (27.84)34 (25.37)15 (35.71)
Intraoperative fluid replacementχ2 = 0.330.566
< 2000 mL78 (44.32)61 (45.52)17 (40.48)
≥ 2000 mL98 (55.68)73 (54.48)25 (59.52)
Postoperative infectionχ2 = 0.690.406
No138 (78.41)107 (79.85)31 (73.81)
Yes38 (21.59)27 (20.15)11 (26.19)
Postoperative feverχ2 = 1.430.233
No122 (69.32)96 (71.64)26 (61.90)
Yes54 (30.68)38 (28.36)16 (38.10)
Anastomotic fistulaχ2 = 9.710.002
No161 (91.48)128 (95.52)33 (78.57)
Yes15 (8.52)6 (4.48)9 (21.43)
Table 2 Univariate logistic regression analysis
Variables
β
SE
Z
P value
OR (95%CI)
Age0.110.042.850.0041.12 (1.04-1.21)
BMI-0.020.05-0.430.6670.98 (0.88-1.09)
Preoperative RBC0.380.271.380.1671.46 (0.85-2.48)
Preoperative WBC0.410.202.080.0381.51 (1.02-2.23)
Preoperative ALB-0.190.07-2.530.0110.83 (0.72-0.96)
Preoperative Hb-0.020.02-1.250.2110.98 (0.94-1.01)
Preoperative PLT0.010.011.790.0731.01 (1.00-1.03)
FEV1%-0.040.01-3.080.0020.96 (0.94-0.99)
FVC%-0.050.02-2.730.0060.95 (0.91-0.99)
Operation time0.010.011.510.1321.01 (1.00-1.03)
Preoperative bleeding0.010.010.940.3491.01 (0.99-1.04)
Sex
Female----1.00 (reference)
Male0.100.370.270.7841.11 (0.54-2.27)
Smoking
No----1.00 (reference)
Yes0.790.362.170.0302.20 (1.08-4.47)
Hypertension
No----1.00 (reference)
Yes0.300.360.810.4151.34 (0.66-2.74)
Diabetes
No----1.00 (reference)
Yes0.760.601.260.2082.13 (0.66-6.90)
Tumor location
Intestine----1.00 (reference)
Stomach0.530.481.110.2681.70 (0.66-4.38)
Liver and gallbladder0.860.481.790.0732.37 (0.92-6.07)
Pancreas0.740.511.450.1462.10 (0.77-5.73)
TNM staging
I/II----1.00 (reference)
III/IV0.840.362.330.0202.32 (1.14-4.70)
Preoperative pulmonary infection
No----1.00 (reference)
Yes0.830.372.240.0252.30 (1.11-4.75)
Surgical method
Laparoscopic surgery----1.00 (reference)
Open surgery0.490.381.300.1941.63 (0.78-3.43)
Intraoperative fluid replacement
< 2000 mL----1.00 (reference)
≥ 2000 mL0.210.360.570.5661.23 (0.61-2.48)
Postoperative infection
No----1.00 (reference)
Yes0.340.410.830.4081.41 (0.63-3.15)
Postoperative fever
No----1.00 (reference)
Yes0.440.371.190.2341.55 (0.75-3.22)
Anastomotic fistula
No----1.00 (reference)
Yes1.760.563.130.0025.82 (1.93-17.51)
Table 3 Multivariate logistic regression analysis
Variables
β
SE
Z
P value
OR (95%CI)
Intercept6.334.671.350.176559.39 (0.06-5308961.64)
Smoking
No----1.00 (reference)
Yes1.150.462.500.0123.17 (1.28-7.84)
Preoperative pulmonary infection
No----1.00 (reference)
Yes1.120.462.430.0153.07 (1.24-7.61)
Anastomotic fistula
No----1.00 (reference)
Yes1.510.662.290.0224.55 (1.24-16.67)
Age0.210.063.80< 0.0011.24 (1.11-1.38)
Preoperative ALB-0.340.11-2.980.0030.71 (0.57-0.89)
FEV1%-0.040.02-2.770.0060.96 (0.93-0.99)
FVC%-0.060.02-2.500.0120.94 (0.89-0.99)
Table 4 Clinical application of the predictive model
Prediction result
Gold standard
Total
ARDS
Non-ARDS
ARDS8412
Non-ARDS84856
Total165268